2026 Annual Meeting | C83 - Core Principles of Brain Tumors

Date Sunday 04/19/26

Time 03:30 PM - 05:30 PM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Maciej M. Mrugala, MD, PhD, MPH, FAAN

Topic(s) Neuro-oncology

Learning Objectives This program provides a comprehensive, clinically focused overview of major brain and nervous system tumors, spanning malignant, non-malignant, and metastatic disease, emphasizing contemporary diagnostic approaches, evidence-based management strategies, and recent advances that are shaping current neuro-oncology practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
03:30 PM - 04:15 PM CDT	Speaker	Primary Brain Tumors, Diagnosis, and Management Patrick Roth, MD
04:15 PM - 05:00 PM CDT	Speaker	Non-malignant Brain and Nervous System Tumors, Diagnosis, and Management Ehab Y. Harahsheh, MBBS
05:00 PM - 05:30 PM CDT	Speaker	Metastatic Brain Tumors and Primary CNS Lymphoma Maciej M. Mrugala, MD, PhD, MPH, FAAN

Faculty Disclosures
Ehab Y. Harahsheh, MBBS	Dr. Harahsheh has nothing to disclose.
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Patrick Roth, MD	Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer INgelheim. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CDR Life. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Desitin Pharma. Patrick Roth, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Laminar. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuraxpharm. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Roth, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OM Pharma. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Roth, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. The institution of Patrick Roth, MD has received research support from MSD. The institution of Patrick Roth, MD has received research support from TME Pharma.

��ɫ��

��ɫ��